Why the study?
To provide guidance to Nordic anaesthesiologists on the perioperative use of cardiac biomarkers in patients undergoing non-cardiac surgery through endorsement of the ESAIC focused guideline.
The Scandinavian Society of Anaesthesiology and Intensive Care Medicine formally endorses the ESAIC guideline on perioperative cardiac biomarker use in non-cardiac surgery.
Answers are grounded in this paper and cite their sources.
Endorsement offers perioperative guidance to Nordic anaesthesiologists; leaves open prospective validation of biomarker-driven decisions.
BACKGROUND: The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the clinical practice guideline "ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation." The guideline can provide guidance to Nordic anaesthesiologists on the perioperative use of cardiac biomarkers in patients undergoing non-cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Rehn et al. (2024) conducted a review in Perioperative risk evaluation in non-cardiac surgery. ESAIC focused guideline for cardiac biomarkers was evaluated on AGREE II Overall assessment score. The Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorsed the ESAIC guideline for perioperative cardiac biomarker use, which received an overall AGREE II score of 83%.
Synapse has enriched 10 related papers. Consider them for comparative context: